InspireMD (NYSE:NSPR) said this week its stockholders approved a 1-for-50 reverse split of its stock, slated to take effect today. The reverse split comes only 13 months after its last 1-for-35 reverse split, which the Israel-based company initiated last February. Through the deal, each shareholder in the company will receive a single share of the company’s […]
InspireMD touts results of ‘one-size-fits-all’ stroke-prevention study
A clinical trial of InspireMD’s (NYSE:NSPR) CGuard embolic prevention stent showed that it successfully treated patients whose carotid arteries varied in size, according to the company. The investigator-initiated trial in Germany used a 10 mm diameter CGuard stent with SmartFit technology across a broad range of carotid artery diameters. Variations in diameters of the common carotid artery (CCA) […]
InspireMD inks distro deal for CGuard in South Africa
InspireMD (NYSE:NSPR) said today that it inked a deal with Torque Medical to distribute its CGuard Embolic Prevention System in South Africa. The Israel-based company reported that it will begin the commercial launch for CGuard in South Africa immediately. “We are extremely pleased with the opportunity to offer CGuard EPS in the South African market. We […]
InspireMD touts results of next-gen stroke prevention stent study
InspireMD (NYSE:NSPR) has released the results of a meta-analysis of four clinical studies involving dual-layered (DLS) and mesh-covered stents, including the company’s MicroNet-covered stent, the CGuard embolic prevention system. The analysis concluded that carotid artery disease patients treated with mesh-covered stents experienced a 30-day minor stroke rate of 1.25%, lower than the 30-day minor stroke rates reported in […]
InspireMD wins regulatory nod in Ecuador for CGuard, MGuard
InspireMD (NYSE:NSPR) said this week it won regulatory approval in Ecuador for its CGuard embolic prevention system and MGuard Prime devices. The approval comes shortly after the company inked an exclusive distribution agreement with Ecuadorian medical device distributor Cardiobene, Israel-based InspireMD said. Both companies have worked together to secure regulatory approvals in the country, InspireMD added. “We […]
InspireMD wins Peruvian nod for CGuard, MGuard
InspireMD (NYSE:NSPR) said yesterday it won regulatory approval from Peru’s Ministry of Health for its CGuard embolic prevention system and MGuard Prime. The Israel-based company said it inked an exclusive distribution agreement with Peru-based medical device distributor Dispositivos Medicos E.I.R.L. “We have been working closely with InspireMD in order to educate key opinion leaders and top hospital […]
7 medtech stories we missed this week: March 2, 2018
From InspireMD’s new distribution deals to Kelynium’s distribution deal with a mystery partner, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. InspireMD inks distribution deals in Greece, Caribbean InspireMD announced in a March 1 press release that it has signed exclusive distribution agreements with T-Vascular IKE Medical Supplies […]
InspireMD pulls trigger on 1-for-35 reverse split
InspireMD (NYSE:NSPR) said yesterday it pulled the trigger on a 1-for-35 reverse stock split. The Israel-based company said its stockholders approved a reverse stock split yesterday at a ratio in the range of 1-for-25 to 1-for-50. Trading under a split adjusted basis on the NYSE began today, the company said, noting that the number of shares of […]
InspireMD touts 2-year CGuard EPS results
InspireMD (NYSE:NSPR) this week released two-year results from the Paradigm 101 clinical study of its CGuard embolic protection system. Results from the trial were initially presented at the 2017 VEITH Symposium in New York last month. In the investigator-led study, researchers examined the use of the CGuard EPS system in 101 patients with symptomatic or high-risk […]
7 medtech stories we missed this week: Oct. 20, 2017
From InspireMD’s distribution deal to RenalGuard touting a new study, here are seven medtech stories we missed this week but thought were still worth a mention. 1. InspireMD inks Chile distribution deal InspireMD announced in an Oct. 12 press release that it has signed a distribution deal with CorpMedical Chile to distribute the MGuard Prime […]
Russian study pits InspireMD’s CGuard device against Abbott’s Rx Acculink carotid stent
InspireMD (NYSE:NSPR) this week touted an independent clinical trial in Russia pitting its CGuard embolic protection device against the Rx Acculink carotid stent made by Abbott (NYSE:ABT). The 100-patient trial is designed to compare the two devices in terms of neuroprotection and clinical superiority in subjects undergoing carotid endarterectomy, the Tel Aviv-based company said. Conducted at the Scientific Research […]
- 1
- 2
- 3
- …
- 6
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube